The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid A Augments Innate Host Resistance to Systemic Bacterial Infection
Open Access
- 1 September 2011
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 79 (9), 3576-3587
- https://doi.org/10.1128/iai.00022-11
Abstract
Monophosphoryl lipid A (MPLA) is a Toll-like receptor 4 (TLR4) agonist that is currently used as a vaccine adjuvant in humans. In this study, we evaluated the effect of MPLA treatment on the innate immune response to systemic bacterial infections in mice. Mice treated with MPLA after burn injury showed improved survival and less local and systemic dissemination of bacteria in a model of Pseudomonas aeruginosa burn wound infection. Prophylactic treatment with MPLA significantly enhanced bacterial clearance at the site of infection and reduced systemic dissemination of bacteria despite causing attenuation of proinflammatory cytokine production during acute intra-abdominal infection caused by cecal ligation and puncture. Administration of MPLA at 1 h after CLP also improved bacterial clearance but did not alter cytokine production. MPLA treatment increased the numbers of granulocytes, double-positive myeloid cells, and macrophages at sites of infection and increased the percentage and total numbers of myeloid cells mediating phagocytosis of bacteria. Depletion of Ly6G + neutrophils, but not macrophages, eliminated the ability of MPLA treatment to improve bacterial clearance. The immunomodulatory effects of MPLA were absent in TLR4-deficient mice. In conclusion, these studies show that MPLA treatment significantly augments the innate immune response to bacterial infection by enhancing bacterial clearance despite the attenuation of proinflammatory cytokine production. The enhanced bacterial clearance is mediated, in part, by increased numbers of myeloid cells with effective phagocytic functions at sites of infection and is TLR4 dependent.This publication has 48 references indexed in Scilit:
- Practical Techniques for Detection of Toll-Like Receptor-4 in the Human IntestinePublished by Springer Science and Business Media LLC ,2009
- Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenalExperimental Neurology, 2008
- Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonistsBlood, 2008
- Functions of the complement components C3 and C5 during sepsisThe FASEB Journal, 2008
- Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9Journal of Investigative Dermatology, 2007
- Effect of Transforming Growth Factor-β Neutralization on Survival and Bacterial Clearance in a Murine Model of Pseudomonas aeruginosa Burn Wound InfectionJournal of Burn Care & Research, 2006
- Lipopolysaccharide EndotoxinsAnnual Review of Biochemistry, 2002
- Endotoxin tolerance—current concepts in historical perspectiveInnate Immunity, 2002
- Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1β, IL6 and TNFαGeneral Pharmacology: The Vascular System, 1996
- Characterization of a Nontoxic Monophosphoryl Lipid AClinical Infectious Diseases, 1987